Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With and Without Diabetic Retinopathy
Clinical trial NCT05296447 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT05296447
- Sponsor
- AbbVie
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-04
- Primary completion
- 2031-06-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.